In tune, a study of a human cervical cancer cell line (Hela cells) had previously demonstrated that E2-activated ERβ acted as a negative regulator of cyclin D1 gene transcription and effectively abrogated the ER-α-mediated activation of cyclin D1 expression when both ER subtypes are co-expressed [54]. The gene discussed is ESR2; the disease is cervical cancer.